Ingen Technologies Inc. (Ingen Technologies), a medical device manufacturer for respiratory patient market in the US and abroad, has been awarded a purchase order from MedOx Corporation (Medox) for 40,000 Oxyview-Nasal Cannulas. The value of the order is $1,00,000.
The cannulas are designed for Adults, Pediatrics and Infants, and include 0-6 liters/minute and a low-flow 0-3 liters/minute unit that is either reusable or comes attached to a high quality 7′ latex free oxygen tube with a curved soft-tip nasal cannula.
The company claims that the Oxyview Nasal Cannula is the only oxygen cannula in the world with a flow meter built-in that provides extremely accurate flow rate readings for the patient and caregiver.
“We are seeing a strong increase in revenues, and expect this trend to continue over the next several years. Our accountants and auditors are diligently working on completion of the SEC filings, specifically the 10-KSB. We anticipate filing a revised annual and quarterly report on the OTC Pink Sheets later next week. The company is progressing forward very nicely at this time and we will continue to make public announcements as each event occurs,” stated Scott R. Sand, Chief Executive Officer and Chairman of the Board.